Cardiología
Servicio
University of Oxford
Oxford, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Oxford (10)
2024
-
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM
Journal of the American Heart Association, Vol. 13, Núm. 15, pp. e035993
-
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4
Journal of Cardiac Failure
2023
-
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45
2021
-
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging
Journal of Clinical Medicine, Vol. 10, Núm. 16
2016
-
Endolysosomal two-pore channels regulate autophagy in cardiomyocytes
Journal of Physiology, Vol. 594, Núm. 11, pp. 3061-3077
-
Human Ischemic Cardiomyopathy Shows Cardiac Nos1 Translocation and its Increased Levels are Related to Left Ventricular Performance
Scientific Reports, Vol. 6
-
Metabolic alterations derived from absence of Two-Pore Channel 1 at cardiac level
Journal of Biosciences, Vol. 41, Núm. 4, pp. 643-658
-
Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated Hearts
Scientific Reports, Vol. 6
2012
-
Increased expression of fatty-acid and calcium metabolism genes in failing human heart
PLoS ONE, Vol. 7, Núm. 6
2008
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
New England Journal of Medicine, Vol. 358, Núm. 15, pp. 1547-1559